Lack of Association Between MIF Gene-173G>C Polymorphism with Multiple Sclerosis

被引:0
作者
Cevik, Betul [1 ]
Yigit, Serbulent [2 ]
Karakus, Nevin [2 ]
Aksoy, Durdane [1 ]
Ates, Omer [2 ]
Kurt, Semiha [1 ]
机构
[1] Gaziosmanpasa Univ, Fac Med, Dept Neurol, TR-60100 Tokat, Turkey
[2] Gaziosmanpasa Univ, Fac Med, Dept Med Biol, TR-60100 Tokat, Turkey
来源
IN VIVO | 2015年 / 29卷 / 01期
关键词
Multiple sclerosis; susceptibility; macrophage migration inhibitory factor (MIF); -173G>C gene polymorphism; promoter polymorphism; MIGRATION INHIBITORY FACTOR; FACTOR GENE; PROMOTER POLYMORPHISMS; DISEASE; EXPRESSION; BLOOD; DEMYELINATION; METAANALYSIS; RESISTANCE; MOLECULES;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: The aim of the present study was to investigate a possible association between the MIF -173G>C polymorphism and MS in Turkish patients. Materials and Methods: The study included 153 MS-patients and 210 controls. Genomic DNA was isolated and genotyped using PCR-RFLP assay for the MIF -173G>C promoter polymorphism (rs755622). Results: There was no statistically significant difference in allele and genotype frequencies between MS-patients and controls (p=0.227 and p=0.157, respectively). Accordingly, no association was observed when the patients were compared against controls in terms of GG versus GC+CC genotypes and GG+GC versus CC genotypes (p=0.324 and p=0.179, respectively). Also, there was no statistically significant association between MIF-173G>C polymorphism and clinical and demographic characteristics of MS-patients. Conlusion: The results of the present study suggest no relation between MS susceptibility and MIF gene 173G>C polymorphism in the examined Turkish population.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 34 条
[1]   Association of Macrophage Migration Inhibitory Factor Gene Promoter Polymorphisms with Multiple Sclerosis in Turkish Patients [J].
Akcali, A. ;
Pehlivan, S. ;
Pehlivan, M. ;
Sever, T. ;
Neyal, M. .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (01) :69-77
[2]  
Amoli MM, 2006, CLIN EXP RHEUMATOL, V24, P576
[3]  
Amoli MM, 2005, J RHEUMATOL, V32, P74
[4]   Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects [J].
Benedek, Gil ;
Meza-Romero, Roberto ;
Andrew, Shayne ;
Leng, Lin ;
Burrows, Gregory G. ;
Bourdette, Dennis ;
Offner, Halina ;
Bucala, Richard ;
Vandenbark, Arthur A. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (05) :1309-1321
[5]   Association of macrophage migration inhibitory factor-173C allele polymorphism with steroid resistance in children with nephrotic syndrome [J].
Berdeli, A ;
Mir, S ;
Ozkayin, N ;
Serdaroglu, E ;
Tabel, Y ;
Cura, A .
PEDIATRIC NEPHROLOGY, 2005, 20 (11) :1566-1571
[6]   Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis [J].
Bhasin, Madhuri ;
Wu, Muzhou ;
Tsirka, Stella E. .
BMC IMMUNOLOGY, 2007, 8 (1)
[7]   MIF, MIF Alleles, and Prospects for Therapeutic Intervention in Autoimmunity [J].
Bucala, Richard .
JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 :S72-S78
[8]   Multiple sclerosis [J].
Compston, Alastair ;
Coles, Alasdair .
LANCET, 2008, 372 (9648) :1502-1517
[9]   In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system [J].
Denkinger, CM ;
Denkinger, M ;
Kort, JJ ;
Metz, C ;
Forsthuber, TG .
JOURNAL OF IMMUNOLOGY, 2003, 170 (03) :1274-1282
[10]   Progress in Multiple Sclerosis Genetics [J].
Goris, An ;
Pauwels, Ine ;
Dubois, Benedicte .
CURRENT GENOMICS, 2012, 13 (08) :646-663